Aprogenex announces launch of genetic testing product; European launch of AproProbe assay represents company's first product launch in genetic testing series.HOUSTON--(BUSINESS WIRE)--May 18, 1995--Aprogenex Inc. (ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. :APG APG Assists Per Game (basketball) APG Assists Per Game (hockey statistic) APG Aberdeen Proving Ground APG Automated Password Generator APG Asia Pacific Group on Money Laundering ) Thursday announced that the company's first genetic testing product, the AproProbe research-use assay, is available for sale in Europe. Zeneca Diagnostics, a business unit of Zeneca Ltd. and the designated distributor for the company's GenSite product, is expected to serve as the distributor for the product in Europe, according to Joel Bresser, Ph.D., president and chief executive officer. "I am proud to announce that Aprogenex has begun the long- awaited commercialization of its technology," stated Bresser. "We expect AproProbe to be the first in a series of genetic testing products for genetic analysis of different types of samples. "In the future, we plan additions to this product line, incorporating different markers for use on maternal blood samples. Other offerings under the AproProbe label are expected to be available before the end of June 1995." The AproProbe research product line may be used to enumerate To count or list one by one. For example, an enumerated data type defines a list of all possible values for a variable, and no other value can then be placed into it. See device enumeration and ENUM. abnormal numbers of chromosomes in various types of samples. In utilizing chromosome probes to enumerate chromosomes 21, 18, 13, X and Y, the procedure can identify disorders such as Down's Syndrome, Edward's Syndrome, Patau's Syndrome, Kleinfelter's Syndrome, XYY Syndrome, Triple X Syndrome triple X syndrome XXX syndrome, see there and Turner's Syndrome. The test can be performed in approximately 30 minutes and requires about 15 minutes of technician time. The European launch of the complete GenSite test, for the identification and genetic screening of fetal cells circulating in maternal blood, is currently scheduled for the second half of 1995. As expected, there can be no assurance regarding the timing and other matters relating to these assays, which are subject to numerous contingencies. Aprogenex develops and intends to manufacture and market DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. probe-based diagnostic test systems based on its proprietary RIGHTechnology, which is broadly applicable to extensive markets in genetics, oncology, virology virology, study of viruses and their role in disease. Many viruses, such as animal RNA viruses and viruses that infect bacteria, or bacteriophages, have become useful laboratory tools in genetic studies and in work on the cellular metabolic control of gene expression and microbiology. The company is in the clinical trial process with components of its GenSite maternal blood prenatal genetic testing assay and in preclinical development with its PapPlus HPV HPV human papillomavirus. HPV abbr. human papilloma virus Human papilloma virus (HPV) diagnostic assay and two HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. diagnostic and staging tests, the Virafy and ViraFlow assays. CONTACT: Aprogenex Inc., Houston J. Donald Payne, 713/748-5114 or Keatinge & Associates Inc., San Diego Richard W. Keatinge, 619/625-2100 or Lippert/Heilshorn & Associates, New York Michele Fasano, 212/838-3777 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion